TSE Fundamental Analysis - TRINSEO PLC

Fundamental Rating

Overall TSE gets a fundamental rating of 2 out of 10. We evaluated TSE against 85 industry peers in the Chemicals industry. TSE may be in some trouble as it scores bad on both profitability and health. TSE does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

TSE had negative earnings in the past year.

TSE had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: TSE reported negative net income in multiple years.

Of the past 5 years TSE 4 years had a positive operating cash flow.

1.2 Ratios

TSE has a worse Return On Assets (-13.26%) than 76.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	-13.26%
ROE	N/A
ROIC	N/A

ROA(3y)-15.93%

ROA(5y)-7.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TSE's Operating Margin has declined in the last couple of years.

TSE has a Gross Margin of 7.92%. This is amonst the worse of the industry: TSE underperforms 84.71% of its industry peers.

In the last couple of years the Gross Margin of TSE has declined.

TSE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.92%

OM growth 3Y-72.52%

OM growth 5Y-32.82%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.

TSE has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, TSE has less shares outstanding

The debt/assets ratio for TSE is higher compared to a year ago.

2.2 Solvency

TSE has an Altman-Z score of 0.97. This is a bad value and indicates that TSE is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 0.97, TSE is not doing good in the industry: 78.82% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	0.97

ROIC/WACCN/A

WACC7.05%

2.3 Liquidity

A Current Ratio of 1.50 indicates that TSE should not have too much problems paying its short term obligations.

TSE has a Current ratio of 1.50. This is in the lower half of the industry: TSE underperforms 65.88% of its industry peers.

TSE has a Quick Ratio of 1.50. This is a bad value and indicates that TSE is not financially healthy enough and could expect problems in meeting its short term obligations.

TSE has a worse Quick ratio (0.95) than 67.06% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.5
Quick Ratio	0.95

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.64% over the past year.

The Revenue has decreased by -5.28% in the past year.

TSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.81% yearly.

EPS 1Y (TTM)9.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%29.38%

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-13.19%

3.2 Future

Based on estimates for the next years, TSE will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.68% on average per year.

TSE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.34% yearly.

EPS Next Y21.95%

EPS Next 2Y22.7%

EPS Next 3Y18.68%

EPS Next 5YN/A

Revenue Next Year-0.36%

Revenue Next 2Y2.01%

Revenue Next 3Y4.34%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TSE. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSE. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

TSE's Enterprise Value to EBITDA is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	13.44

4.3 Compensation for Growth

A more expensive valuation may be justified as TSE's earnings are expected to grow with 18.68% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y22.7%

EPS Next 3Y18.68%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TSE has a Yearly Dividend Yield of 1.34%. Purely for dividend investing, there may be better candidates out there.

The stock price of TSE dropped by -39.19% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.

TSE's Dividend Yield is comparable with the industry average which is at 3.64.

With a Dividend Yield of 1.34, TSE pays less dividend than the S&P500 average, which is at 2.35.

		Industry Rank	Sector Rank
Dividend Yield	1.34%

5.2 History

The dividend of TSE decreases each year by -50.57%.

TSE has paid a dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)-50.57%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

TSE has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-0.45%

EPS Next 2Y22.7%

EPS Next 3Y18.68%

More info and screens

Find the best dividend stocks

Show peers with best dividend

TRINSEO PLC

NYSE:TSE (8/1/2025, 7:00:00 PM)

After market: 2.56 0 (0%)

2.56

-0.11 (-4.12%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)05-07 2025-05-07/amc

Earnings (Next)08-06 2025-08-06/amc

Inst Owners71.35%

Inst Owner Change-0.39%

Ins Owners5.5%

Ins Owner Change29.01%

Market Cap91.26M

Analysts49.09

Price Target4.21 (64.45%)

Short Float %8.1%

Short Ratio6.67

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.34%

Yearly Dividend0.05

Dividend Growth(5Y)-50.57%

DP-0.45%

Div Incr Years0

Div Non Decr Years0

Ex-Date07-10 2025-07-10 (0.01)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-7.45%

Min EPS beat(2)-15.89%

Max EPS beat(2)0.99%

EPS beat(4)1

Avg EPS beat(4)-9.86%

Min EPS beat(4)-15.89%

Max EPS beat(4)0.99%

EPS beat(8)2

Avg EPS beat(8)-68.87%

EPS beat(12)2

Avg EPS beat(12)-54.58%

EPS beat(16)4

Avg EPS beat(16)-41.48%

Revenue beat(2)0

Avg Revenue beat(2)-7.71%

Min Revenue beat(2)-14.85%

Max Revenue beat(2)-0.57%

Revenue beat(4)0

Avg Revenue beat(4)-5.6%

Min Revenue beat(4)-14.85%

Max Revenue beat(4)-0.57%

Revenue beat(8)1

Avg Revenue beat(8)-5.51%

Revenue beat(12)1

Avg Revenue beat(12)-5.88%

Revenue beat(16)3

Avg Revenue beat(16)-4.16%

PT rev (1m)0%

PT rev (3m)-25%

EPS NQ rev (1m)-11.84%

EPS NQ rev (3m)-17.82%

EPS NY rev (1m)-2.68%

EPS NY rev (3m)-30.39%

Revenue NQ rev (1m)-3.03%

Revenue NQ rev (3m)-9.07%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.66%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.03
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	13.44

EPS(TTM)-7.12

EYN/A

EPS(NY)-3.8

Fwd EYN/A

FCF(TTM)-3.21

FCFYN/A

OCF(TTM)-1.63

OCFYN/A

SpS95.2

BVpS-19.05

TBVpS-37.15

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-13.26%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.92%
FCFM	N/A

ROA(3y)-15.93%

ROA(5y)-7.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-72.52%

OM growth 5Y-32.82%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

F-Score4

Asset Turnover1.28

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	12.76
Cap/Depr	27.98%
Cap/Sales	1.66%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.5
Quick Ratio	0.95
Altman-Z	0.97

F-Score4

WACC7.05%

ROIC/WACCN/A

Cap/Depr(3y)41.39%

Cap/Depr(5y)51.15%

Cap/Sales(3y)2.23%

Cap/Sales(5y)2.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)9.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%29.38%

EPS Next Y21.95%

EPS Next 2Y22.7%

EPS Next 3Y18.68%

EPS Next 5YN/A

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-13.19%

Revenue Next Year-0.36%

Revenue Next 2Y2.01%

Revenue Next 3Y4.34%

Revenue Next 5YN/A

EBIT growth 1Y77.12%

EBIT growth 3Y-75.28%

EBIT growth 5Y-32.27%

EBIT Next Year793.49%

EBIT Next 3Y136.74%

EBIT Next 5YN/A

FCF growth 1Y-119.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-161.98%

OCF growth 3YN/A

OCF growth 5YN/A

TRINSEO PLC (TSE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens